Johnson-Greene Treerita Essalima
Transaction: 06/15/2026
BUY
Change
+21,000
Price
$1.23
Filing
06/17/2026
Type
BUY
Ocugen, Inc.
OCGN • Biotechnology
$1.36
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$460.60M
Growth
-15.0%
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 8.2%Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 9, 2026, 12:10 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$1.36
Change0.00%
Shares Out338.68M
Market Cap$460.60M
Enterprise Value$446.81M
52W Range0.96 - 2.73
Beta2.18
P/E-5.63
P/S100.57
P/B-27.82
P/FCF-7.50
EV/Sales97.56
Price$1.36
Change0.00%
Shares Out338.68M
Market Cap$460.60M
Enterprise Value$446.81M
52W Range0.96 - 2.73
Beta2.18
P/E-5.63
P/S100.57
P/B-27.82
P/FCF-7.50
EV/Sales97.56
EV/EBITDA-6.17
EV/FCF-7.28
Earnings Yield-17.76%
FCF Yield-13.33%
Dividend Yield0.00%
Gross Margin45.86%
Oper. Margin-14.26%
Profit Margin-15.37%
Debt/Eq-2.72
Current Ratio1.06
Quick Ratio1.06
Revenue 5Y-15.04%
Target$5.00
Target Upside267.65%
Target Median$5.00
Target Range3.50 - 6.00
Volume4.50M
Avg Volume7.54M
EPS Surprise-0.01
Investment DNA
How strong this company looks for long-term investors
37
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
46/100
Growth Potential
Revenue and expansion
86/100
Price Attractiveness
Cheap or expensive today
20/100
Why this score▼
Positive revenue growth · 8.2%Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 6 analyst votes · 2026-09-05
92/100
Bullish
Bullish
5
Hold
1
Bearish
0
Price Target
2026-08-09
Low
$3.50
Mean
$5.00
Median
$5.00
High
$6.00
Insider Transactions
Recent executive and insider activity
Coleman Blaise
Transaction: 06/11/2026
BUY
Change
+170,100
Price
$1.22
Filing
06/15/2026
Type
BUY
Zhang Junge
Transaction: 06/11/2026
BUY
Change
+170,100
Price
$1.22
Filing
06/15/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Johnson-Greene Treerita Essalima | BUY | +21,000 | $1.23 | 06/15/2026 | 06/17/2026 |
| Coleman Blaise | BUY | +170,100 | $1.22 | 06/11/2026 | 06/15/2026 |
| Zhang Junge | BUY | +170,100 | $1.22 | 06/11/2026 | 06/15/2026 |
| Castillo Kirsten | BUY | +170,100 | $1.22 | 06/11/2026 | 06/15/2026 |
| Chandrasekhar Satishchandran | BUY | +170,100 | $1.22 | 06/11/2026 | 06/15/2026 |
| Kompella Uday | BUY | +170,100 | $1.22 | 06/11/2026 | 06/15/2026 |
| Zhang Junge | SELL | -66,929 | $1.42 | 04/01/2026 | 04/02/2026 |
| Zhang Junge | BUY | +15,000 | $0.51 | 04/01/2026 | 04/02/2026 |
| Johnson-Greene Treerita Essalima | OTHER | +750,000 | $1.44 | 03/04/2026 | 03/05/2026 |
| Johnson-Greene Treerita Essalima | OTHER | 0 | Not reported | 03/04/2026 | 03/05/2026 |
| Ramachandran Ramesh | BUY | +207,300 | Not reported | 01/02/2026 | 01/06/2026 |
| Ramachandran Ramesh | BUY | +310,950 | $1.38 | 01/02/2026 | 01/06/2026 |
| Musunuri Shankar | BUY | +3,123,201 | $1.38 | 01/02/2026 | 01/06/2026 |
| Musunuri Shankar | BUY | +3,123,201 | Not reported | 01/02/2026 | 01/06/2026 |
| Chandrasekhar Satishchandran | OTHER | +25,000 | $2.22 | 06/05/2025 | 06/12/2025 |
| Coleman Blaise | OTHER | 0 | Not reported | 06/05/2025 | 06/09/2025 |
| Chandrasekhar Satishchandran | OTHER | 0 | Not reported | 06/05/2025 | 06/09/2025 |
| Zhang Junge | BUY | +151,316 | $0.95 | 06/05/2025 | 06/09/2025 |
| Kompella Uday | BUY | +151,316 | $0.95 | 06/05/2025 | 06/09/2025 |
| Castillo Kirsten | BUY | +151,316 | $0.95 | 06/05/2025 | 06/09/2025 |